Integral Use of Thromboelastography With Platelet Mapping to Guide Appropriate Treatment, Avoid Complications, and Improve Survival of Patients With Coronavirus Disease 2019–Related Coagulopathy

OBJECTIVES: Coagulopathy of coronavirus disease 2019 is largely described as hypercoagulability, yet both thrombotic and hemorrhagic complications occur. Although therapeutic and prophylactic anticoagulant interventions have been recommended, empiric use of antifactor medications (heparin/enoxaparin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hranjec, Tjasa, Estreicher, Michael, Rogers, ; Bradley, Kohler, Lisa, Solomon, ; Rachele, Hennessy, ; Sara, Cibulas, ; Megan, Hurst, ; Deborah, Hegazy, ; Mohamed, Lee, Jieun, Perez, ; Donny, Doctor, ; Norman, Kiffin, Chauniqua, Pigneri, Danielle, LaGuardia, ; Heather, Shaw, ; Kathryn, Arenas, Juan, Rosenthal, Andrew, Katz, ; Randy S., Sawyer, ; Robert G., Pepe, ;Paul E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769351/
https://www.ncbi.nlm.nih.gov/pubmed/33381763
http://dx.doi.org/10.1097/CCE.0000000000000287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769351/
https://www.ncbi.nlm.nih.gov/pubmed/33381763
http://dx.doi.org/10.1097/CCE.0000000000000287

Ejemplares similares